NPPB
50mg
| ≥99%
CSNpharm
NPPB can act as a blocker of the chloride channel with IC50 of 100 nM-100 µM and inhibitor of cyclooxygenase (IC50 = 8 µM).
More Information
Supplier Page
NPPB
100mg
| ≥99%
CSNpharm
NPPB can act as a blocker of the chloride channel with IC50 of 100 nM-100 µM and inhibitor of cyclooxygenase (IC50 = 8 µM).
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
NPS-2143 HCl is a potent and selective calcium ion-sensing receptor antagonist with IC50 of 43 and 41 nM for cytoplasmic Ca2+ concentrations and parathyroid hormone secretion, respectively.
More Information
Supplier Page
CSNpharm
NPS-2143 HCl is a potent and selective calcium ion-sensing receptor antagonist with IC50 of 43 and 41 nM for cytoplasmic Ca2+ concentrations and parathyroid hormone secretion, respectively.
More Information
Supplier Page
CSNpharm
NPS-2143 HCl is a potent and selective calcium ion-sensing receptor antagonist with IC50 of 43 and 41 nM for cytoplasmic Ca2+ concentrations and parathyroid hormone secretion, respectively.
More Information
Supplier Page
CSNpharm
NPS-2143 HCl is a potent and selective calcium ion-sensing receptor antagonist with IC50 of 43 and 41 nM for cytoplasmic Ca2+ concentrations and parathyroid hormone secretion, respectively.
More Information
Supplier Page
NQ301
50mg
| ≥98%
CSNpharm
NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.
More Information
Supplier Page
NQ301
5mg
| ≥98%
CSNpharm
NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.
More Information
Supplier Page
NQ301
25mg
| ≥98%
CSNpharm
NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.
More Information
Supplier Page
NQ301
100mg
| ≥98%
CSNpharm
NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.
More Information
Supplier Page
NQ301
10mg
| ≥98%
CSNpharm
NQ301, a selective CD45 inhibitor with an IC50 of 200 nM, is also an antithrombotic agent and inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
NS-309 is a positive modulator of small- and intermediate- conductance Ca2+-activated K+ channels (KCa2 and KCa3.1 channels). It increases Ca2+ sensitivity and displays no activity at BK channels.
More Information
Supplier Page
CSNpharm
NS-309 is a positive modulator of small- and intermediate- conductance Ca2+-activated K+ channels (KCa2 and KCa3.1 channels). It increases Ca2+ sensitivity and displays no activity at BK channels.
More Information
Supplier Page
CSNpharm
NS-309 is a positive modulator of small- and intermediate- conductance Ca2+-activated K+ channels (KCa2 and KCa3.1 channels). It increases Ca2+ sensitivity and displays no activity at BK channels.
More Information
Supplier Page
CSNpharm
NS-309 is a positive modulator of small- and intermediate- conductance Ca2+-activated K+ channels (KCa2 and KCa3.1 channels). It increases Ca2+ sensitivity and displays no activity at BK channels.
More Information
Supplier Page
NS-398
100mg
| ≥99%
CSNpharm
NS-398 is a selective inhibitor of COX2 with IC50s of 75 and 1.77 μM for human recombinant COX1 and 2 respectively.
More Information
Supplier Page
CSNpharm
NS-398 is a selective inhibitor of COX2 with IC50s of 75 and 1.77 μM for human recombinant COX1 and 2 respectively.
More Information
Supplier Page
CSNpharm
NS-398 is a selective inhibitor of COX2 with IC50s of 75 and 1.77 μM for human recombinant COX1 and 2 respectively.
More Information
Supplier Page
CSNpharm
NS-398 is a selective inhibitor of COX2 with IC50s of 75 and 1.77 μM for human recombinant COX1 and 2 respectively.
More Information
Supplier Page
CSNpharm
NS-6180 is a channel blocker of KCa3.1 (IC50= 9 nM for rat and 14 nM for human). It can prevent T-cell activation and inflammation.
More Information
Supplier Page
CSNpharm
NS-6180 is a channel blocker of KCa3.1 (IC50= 9 nM for rat and 14 nM for human). It can prevent T-cell activation and inflammation.
More Information
Supplier Page
CSNpharm
NS-6180 is a channel blocker of KCa3.1 (IC50= 9 nM for rat and 14 nM for human). It can prevent T-cell activation and inflammation.
More Information
Supplier Page
CSNpharm
NS-6180 is a channel blocker of KCa3.1 (IC50= 9 nM for rat and 14 nM for human). It can prevent T-cell activation and inflammation.
More Information
Supplier Page
CSNpharm
NS1652 is a reversible anion conductance inhibitor, blocks chloride channel, with an IC50 of 1.6 μM in human and mouse red blood cells.
More Information
Supplier Page
CSNpharm
NS1652 is a reversible anion conductance inhibitor, blocks chloride channel, with an IC50 of 1.6 μM in human and mouse red blood cells.
More Information
Supplier Page
CSNpharm
NS1652 is a reversible anion conductance inhibitor, blocks chloride channel, with an IC50 of 1.6 μM in human and mouse red blood cells.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
NSC305787 is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 HCl is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 HCl is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 HCl is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 HCl is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 HCl is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC305787 HCl is a small molecule inhibitor of PKC, with IC50 of 8.3 μM, 9.4 μM, 55 μM for PKCΙ phosphorylation of recombinant ezrin, of moesin, and of radixin.
More Information
Supplier Page
CSNpharm
NSC319726 is a mutant p53R175 reactivator inhibiting growth of fibroblasts expressing the p53R175 mutation (IC50 = 8 nM) and showing no inhibition for p53 wild-type cells.
More Information
Supplier Page
